And it made waves for injecting the once-iOS-exclusive pinch-to-zoom capability into Android — a move often seen as the spark that ignited Apple’s long-lasting “thermonuclear war” against ...

Microsoft has confirmed that it will be formally disabling TLS (Transport Layer Security) versions 1.0 and 1.1 very soon on Windows. In a blog post titled "TLS 1.0 and TLS 1.1 soon to be disabled ...

Microsoft Teams – a “collaboration platform” that is part of the MS 365 suite of applications – has made numerous changes ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

The 1.1.5 Hotfix patch for The First Descendant has arrived, bringing with it a handful of updates and fixes to improve game stability, balance, and performance. This page acts as a comprehensive ...

The new build adds the Windows Copilot feature for the first time, along with a number of other additions, including some that are a part of today's Dev Channel build. Keep in mind Microsoft is ...

Microsoft defines Copilot+ PC as a Windows 11 device equipped with an NPU of 40 TOPS or more. In other words, even if it has a GPU with high AI processing performance, a PC without an NPU cannot ...

KP.3.1.1 is still the dominant COVID-19 variant in the United States as it accounts for nearly 60% of positive cases, but the XEC variant is not far behind, recent Centers for Disease Control and ...

Backers of Ohio Issue 1, which would overhaul how congressional and statehouse districts are drawn, have raised and spent significantly more than opponents as both sides benefit from out-of-state ...

Fixed an issue where the play-screen display was misaligned in relation to the personal- and world-best replay screens.

Our mission could not be more clear and more necessary: We have a duty to explain what just happened, and why, and what it means for you. We need clear-eyed journalism that helps you understand ...

Novartis is paying Chengdu Baiyu Pharmaceutical $70 million to add to its crop of cancer candidates. The deal, which features $1.1 billion in milestones, covers the global rights to a small ...